Many companies use risk assessments, yet their test protocols remain bloated and cumbersome, with a focus on protocol adherence rather than verification of system functionality. In the September 2011 issue, Peter Watler introduces the ASTM E 2500-07 international industry consensus standard for conducting risk-based design and qualification of GMP manufacturing systems.It uses risk- and science-based practices to focus on critical aspects affecting equipment systems throughout their design-qualification-operation lifecycle.This moves the process from a rigid, protocol-enforced accumulation of documentation to meaningful evaluation of system performance and output quality relating to products and patients.
Included here are larger versions of the example documents Watler provided in his article.
Please join us for a free webinar discussing the purification challenges associated with antibody fragment purification and new solutions for a platform approach.
Wednesday 9 May 2012
Register for this free webinar today
We will present:
• A platform approach for purification of antibody fragments (Fabs)
• New chromatography media (resins) developed for industrial-scale capture of Fabs
• A complete purification process for a Fab developed using high-throughput tools
Register for this free webinar today
Speaker:
Gustav Rodrigo
Senior Scientist, R&D
GE Healthcare Life Sciences

